✕
简体中文English
News
MediBeacon Enters into $30 Million Investment and Exclusive Commercialization Partnership in Greater China with Huadong Medicine
Wednesday, July 31st, 2019
MediBeacon and Huadong Medicine will collaboratively work to reach regulatory approval on MediBeacon’s entire portfolio of assets in Greater China ST. LOUIS, July 31, 2019
News
FDA Grants Breakthrough Device Status for MediBeacon’s Transdermal GFR Measurement System
Monday, October 22nd, 2018
MediBeacon’s Breakthrough Device is Intended to Measure GFR in Patients with Impaired or Normal Kidney Function ST. LOUIS, October 22, 2018 – MediBeacon Inc., whose
News
MediBeacon Presents Gastrointestinal Permeability Research
Saturday, May 6th, 2017
(CHICAGO – May 6, 2017) – Dr. Richard B. Dorshow, Ph.D., Chief Scientific Officer of MediBeacon and Phillip I. Tarr MD, Director of the Division
News
MediBeacon™ Inc. Completes Successful Clinical Study of Transdermal Glomerular Filtration Rate Monitor on Impaired Kidney Function Subjects
Thursday, March 2nd, 2017
Expanded Multicenter Study in U.S. and Europe to Begin Fourth Quarter 2017 (SAINT LOUIS, MO, March 2, 2017) – MediBeacon Inc., a portfolio company within
News
MediBeacon Presents Multiple Papers at SPIE Photonics West
Tuesday, January 31st, 2017
Transdermal Fluorescent Detection Technology for Use in Nephrology Advances (SAN FRANCISCO, January 30, 2017) – Three papers related to continued advances in the use of
News
Gates Foundation Awards $1.1 Million Grant for MediBeacon™ Collaboration with Washington University
Tuesday, October 18th, 2016
MediBeacon Inc. Collaborates with Washington University in $1.1 Million Grant for Groundbreaking Research in Global Health and Development (SAINT LOUIS, MO, October 18, 2016) –
News
National Institutes of Health Awards SBIR Grant to MediBeacon™ Inc.
Thursday, September 8th, 2016
NIH Grant to Support Research on MediBeacon Fluorescent Tracer Agent Use in Ocular Angiography (SAINT LOUIS, MO, August 8, 2016) – MediBeacon announced today that
News
MediBeacon™ Inc. Chief Executive Officer Speaks with Entrepreneur Quarterly
Thursday, July 7th, 2016
Founder Series Interview with Steven Hanley (SAINT LOUIS, MO, July 7, 2016) – Mr. Steven J. Hanley, Chief Executive Officer and co-founder of MediBeacon spoke
News
MediBeacon™ Inc. Acquires Mannheim Pharma & Diagnostics
Wednesday, June 8th, 2016
Technology enables kidney function measurement in preclinical applications (ST. LOUIS – June 8, 2016) – St. Louis-based MediBeacon™ Inc., maker of proprietary, non-invasive, real-time monitoring
News
OSA Biomedical Optics Conference Highlights Commercial Research
Thursday, May 5th, 2016
MediBeacon™ Inc. Chief Scientific Officer Participates on Three Industry Day Panels (FORT LAUDERDALE, FL, April 27, 2016) – Dr. Richard B. Dorshow, Ph.D., President, Chief
News
New MediBeacon Translational Research Presented at SPIE Photonics West
Wednesday, February 3rd, 2016
MediBeacon™ Inc. Presents Preliminary Research Findings on Novel Gastrointestinal Permeability Measurement Technique (SAN FRANCISCO, CA, January 30, 2016) – Dr. Richard B. Dorshow, Ph.D., President,
News
MediBeacon™ Inc. Appoints Dr. Steven B. Miller to Board of Directors
Tuesday, November 17th, 2015
(ST. LOUIS, MO – November 17, 2015) – St. Louis-based MediBeacon™ Inc., maker of a proprietary noninvasive real-time monitoring system for kidney function, today announced
News
MediBeacon™ Inc. Presents Human Clinical Trial Results
Thursday, November 5th, 2015
(SAN DIEGO – November 5, 2015) – St. Louis-based MediBeacon™ Inc., maker of a proprietary noninvasive real-time monitoring system for kidney function, today presented the
News
MediBeacon featured on Fox 2 News, St. Louis
Thursday, September 3rd, 2015
MediBeacon TM Inc., maker of a proprietary noninvasive real-time monitoring system for kidney function, was covered on St. Louis’ local affiliate, Fox 2 News. Below
News
MediBeacon™ Inc. Enters into Agreement for $22.4 Million Investment to Bring Breakthrough Noninvasive Real-Time Kidney Monitoring to Market
Wednesday, August 26th, 2015
Proprietary Optical Renal Function Monitor recently completed first human clinical trials (ST. LOUIS, MO – August 26, 2015) – St. Louis-based MediBeacon TM Inc., maker
News
Washington University School of Medicine, in Collaboration with MediBeacon, Receives Grand Challenges Explorations Grant
Wednesday, June 4th, 2014
Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development (ST. LOUIS, June 4, 2014) – Washington University School of Medicine in St.
News
One Health Summit Highlights Emerging Technology Breakthroughs
Monday, March 10th, 2014
MediBeacon™ Presents “Partnering to Improve Kidney Health” (KANSAS CITY, KS, March 10, 2014) – The 5th Annual One Health Summit was held at Sporting Park in
News
SPIE Photonics West Highlights Translational Research
Monday, February 3rd, 2014
MediBeacon™ Presentation Highlighted as Bench-to-Bedside Translational Research (SAN FRANCISCO, CA, February 3, 2014) – Dr. Richard B. Dorshow, Ph.D., President, Chief Scientific Officer and Founder of
News
Venture Summit in Boston Recognizes MediBeacon
Wednesday, December 11th, 2013
MediBeacon™ Selected as “Best Presenter” in The Life Sciences/Healthcare Track (BOSTON, MA, December 11, 2013) – The 2013 edition of The New England Venture Summit featured
News
Renal Business Today “Renal Function Monitoring”
Friday, November 22nd, 2013
Article by Dr. Dorshow is Featured in the November 2013 Issue of Renal Business Today (ST. LOUIS, November 2013) – Renal Business Today published in
News
Medical Device Company MediBeacon Primed for Growth and Commercial Success at One-Year Anniversary
Wednesday, August 21st, 2013
Company’s success moves it closer toward launching innovative kidney function monitor (ST. LOUIS, Aug. 21, 2013) – This month, as MediBeacon reaches its one-year anniversary,
News
MediBeacon Highlighted in Missouri Business Alert
Saturday, August 3rd, 2013
One On One: Terence Stern, MediBeacon Vice President (ST. LOUIS, August 3, 2013) – MediBeacon LLC, Vice President Business Development, Terence Stern recently spoke with Missouri
News
City and county launch initiative to invest in — and keep — start-ups
Thursday, June 13th, 2013
MediBeacon is highlighted in the St. Louis Beacon™ (ST. LOUIS, June 13, 2013) – Richard Dorshow, MediBeacon Founder and Chief Scientific Officer was interviewed in
News
InvestMidwest 2013 Highlights Medical Device Innovations
Thursday, April 4th, 2013
MediBeacon™ Presents at 2013 InvestMidwest Venture Capital Forum (KANSAS CITY, MO, April 4, 2013) – The 2013 edition of the InvestMidwest Venture Capital Forum featured a
News
MediBeacon Participates in Launch of 2013 Startup Challenge
Wednesday, April 3rd, 2013
Edward Jones and St. Louis Economic Council Unveil Business Competition (ST. LOUIS, April 3, 2013) – MediBeacon LLC, winner of the 2012 edition of the
News
SPIE Photonics West Highlights Fluorescent Tracer Technology
Monday, February 4th, 2013
MediBeacon™ Presents a Poster Presentation at SPIE Photonics West 2013 (SAN FRANCISCO, February 4, 2013) – Dr. Richard B. Dorshow, Ph.D., President, Chief Scientific Officer and
News
Technology Entrepreneurs Meet With Lawmakers in Jefferson City, MO
Wednesday, January 16th, 2013
MediBeacon™ Meets with Missouri Legislators at The State Capital (ST. LOUIS, January 16, 2013) – Technology Entrepreneur Day was held today at the state capital
News
St. Louis Small Business Monthly “The Ones to Watch”
Tuesday, January 1st, 2013
MediBeacon™ is Featured in the January 2013 Issue of St. Louis Small Business Monthly     (ST. LOUIS, January 2013) – Steve Hanley and Dr. Richard
News
BioSTL News Update – MediBeacon Announced as Winner St. Louis Regional Business Plan Competition
Wednesday, October 31st, 2012
MediBeacon, a new St. Louis-based optical diagnostic company, has won the 2012 St. Louis Regional Business Plan Competition, beating out some of the most innovative
News
BioSTL – St. Louis startup MediBeacon launched
Tuesday, August 28th, 2012
BioSTL fosters collaborative efforts and builds regional infrastructure to achieve St. Louis’ potential in biosciences. BioSTL issued the following News Update on August 27, 2012.
News
MediBeacon highlighted in St. Louis Business Journal, August 24, 2012
Monday, August 27th, 2012
Hanley buys Mallinckrodt patents for MediBeacon Premium content from St. Louis Business Journal by Amir Kurtovic, Reporter MediBeacon Co-founders Steve Hanley (left) and Rick Dorshow
News
MediBeacon featured on NBC 5 News, St. Louis
Friday, August 24th, 2012
On August 24th, 2012, Medibecon was covered on St. Louis’ local new affiliate, KSDK. During the interview they discussed Medibeacon in it’s early stages as
News
Missouri Technology Corporation makes investments in St. Louis startups through its TechLaunch Program
Friday, August 24th, 2012
JEFFERSON CITY – The Missouri Technology Corporation (MTC) today announced investments in two St. Louis-based start-up companies through its TechLaunch program. MTC made a $45,000
News
MediBeacon Acquires Optical Diagnostic Agent Development Program
Friday, August 24th, 2012
Innovative Renal Monitoring Platform Will Be First Product (ST. LOUIS, August 24, 2012) — MediBeacon LLC, a St. Louis-based start-up in optical diagnostics, is proud

United States
425 N. New Ballas Road
Suite 100
St. Louis, MO 63141
P: (314) 735-0968

Germany
Cubex41
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
P: +49 (0)621-150283-15

Greater China
華東醫藥股份有限公司
聯繫電話：4008-269-985
+86-(0)571-89908581
郵遞區號：310011
地址：中國浙江省杭州市拱墅區莫幹山路866號
郵箱：info@eastchinapharm.com

科學技術 工作原理 研發技術平臺 產品線 專利權 臨床前動物實驗研究 臨床研究 專注領域 腎臟疾病研究 胃腸道疾病研究 眼科研究 外科技術 研究發現 投資者 為什麼重要 公司概述 數字
應用文獻 MediBeacon 文獻 臨床前動物實驗研究文獻 行業文獻 公司 歷史 科學家 品質承諾 新聞/媒體 聯繫我們 獲取最新資訊 投資者 常見問題

* MediBeacon 的各個產品線均處於臨床開發的不同階段，尚未批准用於人體。

**經皮GFR監測系統（TGFR）用於檢查腎功能受損或正常人的腎絲球過濾率（GFR），本網站使用的文獻中涉及到的“腎臟功能”或者“腎功能”均指GFR檢測。

抓住新機遇，攜手贏未來！華東醫藥 – MediBeacon聯合推廣的敏狄康™參加2020年中國生理學會學術年會
  華東醫藥- MediBeacon聯合推廣的敏狄康™ TGFR腎功能監測及智能分析系統參加2020年8月22-23日中國生理學會學術年會在線會議。2020年8月22日上午8:00中國生理學會學術年會以在線方式正式開幕，實現了生理學同道的雲相聚。開幕式由學會秘書長首都醫科大學李俊發教授主持，理事長北京大學王韻教授代表學會致開幕詞。  
- Read More
MediBeacon Inc. hires Vice President of Research and Development
MediBeacon has hired James M.
- Read More

Terms and Conditions | Privacy Policy | © 2021 MediBeacon All Rights Reserved.

COOKIE CONSENT: We use cookies and similar technologies to recognize your repeat visits and preferences, as well as to analyze traffic, among other things. To learn more about cookies, view our Privacy Policy. By clicking “I Accept” on this banner, or using our site, you consent to the use of cookies unless you have disabled them.